Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,992 | -200,042 | -141,395 | -94,741 | -43,691 |
| Depreciation Amortization | 3,226 | 5,931 | 4,080 | 1,440 | 673 |
| Income taxes - deferred | 49 | -3,742 | -706 | N/A | N/A |
| Accounts receivable | -512 | -1,419 | -863 | N/A | N/A |
| Other Working Capital | -7,967 | 1,522 | -10,067 | -9,330 | -9,854 |
| Other Operating Activity | 10,353 | 47,603 | 30,402 | 24,960 | 7,936 |
| Operating Cash Flow | $-49,843 | $-150,147 | $-118,549 | $-77,671 | $-44,936 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -91,680 | 1,442 | -34,334 | -5,631 | 2,436 |
| PPE Investments | -732 | -5,951 | -5,520 | -4,608 | -2,878 |
| Investing Cash Flow | $-92,412 | $-4,509 | $-39,854 | $-10,239 | $-442 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 272,536 | 30,000 | 30,000 | N/A |
| Debt Repayment | -71 | -80,193 | -118 | -47 | N/A |
| Common Stock Issued | 265 | 100,104 | 98,524 | 58,465 | 155 |
| Common Stock Repurchased | -261 | -1,282 | -1,010 | -657 | -657 |
| Other Financing Activity | -28 | -18,450 | -5,000 | -5,000 | 0 |
| Financing Cash Flow | $-95 | $272,715 | $122,396 | $82,761 | $-502 |
| Exchange Rate Effect | 80 | -131 | -363 | -680 | -95 |
| Beginning Cash Position | 187,413 | 69,485 | 69,485 | 69,485 | 69,485 |
| End Cash Position | 45,143 | 187,413 | 33,115 | 63,656 | 23,510 |
| Net Cash Flow | $-142,270 | $117,928 | $-36,370 | $-5,829 | $-45,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,843 | -150,147 | -118,549 | -77,671 | -44,936 |
| Capital Expenditure | -732 | -5,951 | -5,520 | -4,608 | -2,878 |
| Free Cash Flow | -50,575 | -156,098 | -124,069 | -82,279 | -47,814 |